NCT00078806View on ClinicalTrials.gov

Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

PHASE3TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 4, 2001

Primary Completion Date

May 6, 2004

Study Completion Date

May 6, 2004

Conditions
Juvenile Rheumatoid Arthritis
Interventions
DRUG

Etanercept

Administered by subcutaneous injection twice a week

DRUG

Placebo

Administered by subcutaneous injection twice a week

Sponsors

Lead Sponsor

Amgen

Collaborators (1)

Immunex Corporation
All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

lead

Amgen

INDUSTRY